CAS 2376577-06-7

M2N12

CAS : 2376577-06-7

M2N12

Degré de pureté : ≥98%

Masse moléculaire : 393.83g/mol

Ref: 54-BUP05516

M2N12

CAS : 2376577-06-7

M2N12 selectively inhibits Cdc25C (IC50=0.09μM) and has anti-tumor properties, affecting Cdc25A and B as well.

Formule : C₂₀H₁₆ClN₅O₂

Degré de pureté : 98.01%

Couleur et forme : Solid

Masse moléculaire : 393.83

Ref: TM-T11929

M2N12

CAS : 2376577-06-7

M2N12 is a potent anticancer inhibitor that targets protein kinases in human and Chinese cancer cells. This analog has been shown to induce apoptosis, or programmed cell death, in tumor cells by inhibiting the activity of specific kinases. M2N12 has been isolated from medicinal urine and shows promising potential as an effective treatment for various cancers. As a kinase inhibitor, M2N12 blocks the signaling pathways that promote cancer cell growth and proliferation, making it a valuable tool in cancer research and therapy. Its unique mechanism of action makes it a promising candidate for future drug development.

Formule : C₂₀H₁₆ClN₅O₂

Degré de pureté : Min. 95%

Masse moléculaire : 393.8 g/mol

Ref: 3D-BVD57706